Traders purchased shares of CVS Health Corporation (NYSE:CVS) on weakness during trading hours on Thursday. $72.76 million flowed into the stock on the tick-up and $51.36 million flowed out of the stock on the tick-down, for a money net flow of $21.40 million into the stock. Of all stocks tracked, CVS Health Corporation had the 18th highest net in-flow for the day. CVS Health Corporation traded down ($0.37) for the day and closed at $97.18

Several analysts have recently weighed in on the stock. FBR & Co reaffirmed a “buy” rating on shares of CVS Health Corporation in a research note on Saturday, May 14th. Macquarie reaffirmed an “outperform” rating and set a $115.00 price target on shares of CVS Health Corporation in a research note on Thursday, May 5th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $115.00 price target (up previously from $110.00) on shares of CVS Health Corporation in a research note on Wednesday, May 4th. Leerink Swann reissued a “buy” rating and issued a $110.00 price objective on shares of CVS Health Corporation in a research note on Thursday, May 5th. Finally, Mizuho reissued a “buy” rating and issued a $117.00 price objective (up previously from $104.00) on shares of CVS Health Corporation in a research note on Wednesday, May 4th. Six analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $113.02.

The firm has a 50-day moving average price of $96.32 and a 200 day moving average price of $98.44. The stock has a market capitalization of $103.42 billion and a price-to-earnings ratio of 22.31.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings data on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.02. The firm earned $43.70 billion during the quarter, compared to analyst estimates of $44.28 billion. CVS Health Corporation’s revenue for the quarter was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.19 earnings per share. Analysts expect that CVS Health Corporation will post $5.86 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Monday, August 1st. Investors of record on Thursday, July 21st were given a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date was Tuesday, July 19th.

Other hedge funds and institutional investors have modified their holdings of the company. I.G. Investment Management LTD. increased its position in shares of CVS Health Corporation by 2.0% in the fourth quarter. I.G. Investment Management LTD. now owns 400,725 shares of the pharmacy operator’s stock valued at $39,179,000 after buying an additional 8,028 shares during the last quarter. Johnson Financial Group Inc. increased its position in shares of CVS Health Corporation by 65.0% in the fourth quarter. Johnson Financial Group Inc. now owns 23,099 shares of the pharmacy operator’s stock valued at $2,258,000 after buying an additional 9,100 shares during the last quarter. Wellington Shields Capital Management LLC increased its position in shares of CVS Health Corporation by 7.8% in the fourth quarter. Wellington Shields Capital Management LLC now owns 43,950 shares of the pharmacy operator’s stock valued at $4,297,000 after buying an additional 3,193 shares during the last quarter. Bank of The Ozarks increased its position in shares of CVS Health Corporation by 7.9% in the fourth quarter. Bank of The Ozarks now owns 17,472 shares of the pharmacy operator’s stock valued at $1,708,000 after buying an additional 1,282 shares during the last quarter. Finally, Garcia Hamilton & Associates LP DE increased its position in shares of CVS Health Corporation by 1.9% in the fourth quarter. Garcia Hamilton & Associates LP DE now owns 54,307 shares of the pharmacy operator’s stock valued at $5,310,000 after buying an additional 1,027 shares during the last quarter.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.